课题基金 / 基金详情

Integrated PhD Biomedical Science

Integrated PhD Biomedical Science
生物医学综合博士
批准号:
2880761
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Alzheimer's Disease (AD) is a chronic neurodegenerative disease characterised by abnormal protein accumulation in the form of beta-amyloid plaques and tau tangles. Most cases of AD are sporadic and have a multifactorial basis, manifesting from a mix of genetic predisposition and environmental factors. Genome wide association studies have mapped out the genetic basis of AD identifying common, but low risk changes in genes associated with the structure and function of the innate immune cells of the central nervous system, the microglia. Whereas environmental drivers of AD include age, infection, diet, and pollutant exposure. In AD, changes to the microglia and the development of plaques and tangles occur prior to symptom onset and possibly originate from the actions of environmental factors altering the cell biology of the brain. Thus, this project sets out to establish how environmental factors potentially prime or affect the differentiation of the microglia, altering the chance of an individual developing AD. To model these effects, we will use an in vitro human-derived 3D brain organoid model integrated with microglia exposed to differing environmental factors, creating a complex environment that mimics potential structural and functional differences that occur in the context of AD within the brain. Once this model has been established, we will use AD-derived human cell lines to further explore the relationship between genetic predisposition and the environment. Together this project will provide information on how the genetic-environment relationship alters an individual's chance of developing AD, potentially leading to new public health guidance and legislation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
脯氨酸羟化酶PHD3在草鱼抗GCRV病毒感染与低氧耐受中的功能和机制解析及新种质创制
基于多组学整合与D-MPNN算法的石榴抗肾性贫血PHD2抑制剂开发与验证
  • 批准号:
    JCZRLH202600664
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
PHD2介导RIPK1羟基化调控PASMCs坏死性凋亡促进低氧性肺动脉高压机制及君仁补肺益心颗粒干预研究
PHD2/VHL-HIF-1α介导的糖酵解调控巨噬细胞极化抗溃疡性结肠炎的作用机制及芍药汤的影响